VENLO, The Netherlands, November 2, 2011 /PRNewswire/ -- - Met targets for third quarter of 2011: Net sales grow 5% (+1% CER) to $288.9 million

VENLO, The Netherlands and MELBOURNE, Australia, August 29, 2011 /PRNewswire/ -- QIAGEN N.V.

VENLO, The Netherlands, August 9, 2011 /PRNewswire/ -- QIAGEN N.V.

VENLO, The Netherlands, August 3, 2011 /PRNewswire/ -- QIAGEN N.V.

VENLO, The Netherlands, July 25, 2011 /PRNewswire/ -- - Improving results in second quarter of 2011: Net sales grow 7% (+1% CER) to $282.2 million, adjusted EPS rises to $0.23 and free cash flow jumps 31% to $37.8 million - Expansion strategy in 2011 achieves progress toward accelerating growth in 2012: - Strengthening leadership in Personalized Healthcare: First U.S.